Brief Title
Identification of New Markers in the Hypereosinophilic Syndrome
Official Title
Identification of New Markers in the Hypereosinophilic Syndrome
Brief Summary
The purpose is to characterize new hypereosinophilic syndrome biomarkers more informative and more accessible compared to those that we have already thanks to a proteomic approach. This will help the investigators to diagnose the this disease.
Study Type
Interventional
Primary Outcome
The aim is to characterize, through an approach immunoprotéomique, new HES biomarkers more informative and easier access than those currently available to us. These biomarkers will help to the diagnosis of HES, compared with other causes of eosinophilia.
Condition
Hypereosinophilic Syndrome
Intervention
biologie sample
Study Arms / Comparison Groups
Hypereosinophilic syndrome unexplained
Description:
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Biological
Estimated Enrollment
41
Start Date
June 29, 2010
Completion Date
July 2015
Primary Completion Date
July 2015
Eligibility Criteria
Inclusion Criteria: - dated and signed informed consent - virale serology negative or negative result less than 6 months - virale serology negative for HBV or vaccinated patient - insured - virale serology negative or negative result less than 6 months - negative pregnancy test or female menopause for at least 1 year Exclusion Criteria: - subject enable adult, under guardianship or under protective measures of justice - Refusal or inability to give informed consent - The hypereosinophilic syndrome explained origin other than than atopy, bullous pemphigoid, the Churg-Strauss syndrome and DRESS
Gender
All
Ages
18 Years - 80 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Contacts
Lionel Prin, MD PhD, ,
Location Countries
France
Location Countries
France
Administrative Informations
NCT ID
NCT01713504
Organization ID
2008_29
Secondary IDs
2009-A00314-53
Responsible Party
Sponsor
Study Sponsor
University Hospital, Lille
Study Sponsor
Lionel Prin, MD PhD, Principal Investigator, University Hospital, Lille
Verification Date
February 2019